Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Portfolio Pulse from Lisa Levin
Wall Street analysts have updated their price targets and ratings for several companies. Keybanc raised monday.com's target, while Raymond James, Bernstein, Barclays, Baird, Piper Sandler, Canaccord Genuity, TD Cowen, and HC Wainwright & Co. made various adjustments for other firms. These changes could influence the stock performance in the short term.
November 14, 2023 | 12:38 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler decreased Cara Therapeutics' target from $12 to $1 and downgraded the stock from Overweight to Neutral. Shares fell 0.9% to $1.17.
The drastic reduction in price target and downgrade in rating could significantly dampen investor confidence.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Raymond James lowered Passage Bio's price target from $9 to $5 but maintained an Outperform rating. The stock closed at $0.60.
Despite maintaining an Outperform rating, the significant price target cut could negatively impact investor sentiment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Canaccord Genuity cut The Beauty Health Company's target from $10 to $2.5 and downgraded the stock from Buy to Hold. Shares plummeted 49% to $1.99.
The severe target cut and downgrade, along with the stock's pre-market plunge, indicate a strong negative short-term impact.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 95
NEUTRAL IMPACT
HC Wainwright & Co. reduced BioNTech's target from $180 to $133 but maintained a Buy rating. Shares edged up 0.2% to $98.09.
The price target cut may be mitigated by the maintained Buy rating, likely leading to a neutral short-term impact.
CONFIDENCE 70
IMPORTANCE 55
RELEVANCE 65
NEUTRAL IMPACT
Bernstein lowered The J. M. Smucker Company's target from $123 to $119 and upgraded the stock to Market Perform. Shares fell 0.5% to $108.20.
The downgrade in price target is offset by the upgrade in stock rating, likely resulting in a neutral impact.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Telsey Advisory Group increased Abercrombie & Fitch's price target from $62 to $74 and maintained an Outperform rating. Shares fell 0.9% to $66.39.
The raised price target and positive rating indicate a potential upside, despite the slight share price drop.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Baird increased Aspen Technology's target from $194 to $202 and upgraded the stock from Neutral to Outperform. Shares rose 1.7% to $169.15.
The positive adjustments in price target and rating by Baird are likely to contribute to a continued upward trend.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 85
POSITIVE IMPACT
Keybanc raised monday.com's price target from $180 to $185 and maintained an Overweight rating. The stock rose 10.5% to close at $154.83.
The price target increase and Overweight rating by Keybanc, coupled with the stock's recent rise, suggest a positive short-term outlook.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Barclays raised The Mosaic Company's price target from $40 to $42 and upgraded the stock from Underweight to Overweight. Shares gained 2.6% to $34.50.
The upgrade in both price target and stock rating by Barclays suggests a positive short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
TD Cowen lowered Surgery Partners' target from $39 to $35 but upgraded the stock from Market Perform to Outperform. Shares rose 3.2% to $27.55.
The upgrade to Outperform may outweigh the lowered price target, suggesting a positive short-term impact.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 75